M. L. Uhrig et al. / Tetrahedron: Asymmetry 21 (2010) 2435–2440
2439
The same reduction of 5a conducted at 25 °C, afforded a mixture
of 6a and its -threo isomer (Table 1). Anomeric signals for 2-(S)-
-threo-hexopyranoside: dH-1 = 4.81 ppm, dC-1
for 6 h. TLC showed a single spot of Rf = 0.55 (hexane/EtOAc 2:1).
After evaporation of the solvent under reduced pressure, and fur-
ther purification by column chromatography, compound 8 was iso-
a
-D
octyl 3,4-dideoxy-
a-D
=
96.5 ppm.
lated (410 mg, 82%); [
200 MHz) 7.82, 7.35 (2d, 4H, H-aromatic), 5.20 (d, 0.6H,
J1,2 = 3.3 Hz, H-1 ), 4.67 (d, 0. 4H, J1,2 = 7.5 Hz, H-1b), 4.45 (dd,
0.6H, J1,2 = 3.3, J2,3ax = 4.9, J2,3ax = 12.0 Hz, H-2 ), 4.23–4.05 (m,
1H, H-2b, H-5 ), 3.67 (m, 0. 4H, H-5b), 3.42–3.19 (m, 2H, H-6 /b,
H-60a/b), 2.45 (s, 3H, ArCH3), 2.29–1.37 (m, 4H, H-3 /b, H-30a/b,
H-4
/b, H-40a/b); 13C NMR (CDCl3, 50.3 MHz) d 130.0, 129.8,
128.8, 127.8 (C-aromatic), 95.9 (C-1b), 90.1 (C-1 ), 79.2, 76.8,
74.8, 66.9 (C-2 /b, C-5 /b), 54.3, 54.0 (C-6 /b), 28.5, 27.4, 22.8,
21.7 (C-3 /b, C-4 /b). Anal. Calcd for C13H17N3O5S: C, 47.70; H,
5.23; N, 12.84. Found: C, 47.90; H, 5.46; N, 13.03.
a]
D = +14.0 (c 1.1, CHCl3). 1H NMR (CDCl3,
d
4.2.3. 2-Propyl 3,4-dideoxy-
a
-
D
-erythro-hexopyranoside 5b
a
The reduction of the keto compound 4b15 with NaBH4 was per-
formed at ꢀ18 °C and 25 °C as described above for 4a. After O-
deacetylation the crude product was analyzed by NMR which
a
a
a
a
showed the presence of 5b and its
a-
D-threo isomer (Table 1). Ano-
a
meric signals for 2-propyl 3,4-dideoxy-
a
-D
-threo-hexopyranoside:
a
dH-1 = 4.79 ppm, dC-1 = 97.4 ppm.
a
a
a
a
a
4.2.4. 2-(S)-Octyl 2,6-di-O-tosyl-3,4-dideoxy-a-D-erythro-
hexopyranoside 6
Diol 5b (1.00 g, 3.84 mmol) and tosylchloride (1.82 g, 9.60mmol)
were dissolved in pyridine (50 mL) and the reaction mixture was
stirred at room temperature for 20 h. Next, MeOH was added at
0 °C and the solventwas evaporated in vacuo. Purificationby column
chromatography (hexane/EtOAc, 9:1) afforded the ditosylate 6
4.2.7. 6-Azido-2-O-tosyl-3,4,6-trideoxy-D-erythro-hexono-1,5-
lactone 9
A solution of oxalyl chloride (1.03 mL, 12.22 mmol) in dry
CH2Cl2 (13 mL) was prepared in a round-bottomed flask, under
an Ar atmosphere, and it was cooled to ꢀ78 °C (dry ice/acetone
bath). A solution of DMSO (1.73 mL, 24.44 mmol) dissolved in
CH2Cl2 (2 mL) was added dropwise over a period of 15 min. After
stirring the mixture for 10 min, a solution of compound 8 (2.00 g,
6.11 mmol) in dry CH2Cl2 (6 mL) was added dropwise and stirring
maintained for 1 h. Triethylamine (3 mL) was added and, after
15 min, water (20 mL) was added. The mixture was allowed to
reach room temperature and extracted with 5% aq HCl. The organic
layer was concentrated to afford 9 (1.67 g, 88%) as a white solid
(Rf = 0.70, hexane/EtOAc 1:1). The lactone did not resist purifica-
tion by column chromatography, but the crude product was pure
enough to be used in the following step. Recrystallization from a
minimum amount of EtOAc afforded an analytical sample. Mp
(1.92 g, 88%, Rf = 0.60 hexane/EtOAc 2:1); [a]D = +68.9 (c 1.0, CHCl3);
1H NMR (CDCl3, 500 MHz) d 7.76, 7.78 (2d, 4H, J = 8.0 Hz, H-aro-
matic), 7.33 (2d, 4H, J = 8.0 Hz, H-aromatic), 4.78 (d, 1H, J = 3.5 Hz,
H-1), 4.33 (ddd, 1H, J1,2 = 3.5, J2,3eq = 4.8, J2,3ax = 12.4 Hz, H-2), 3.99
(m, 1H, H-5), 3.96 (dd, 1H, J5,6a = 5.2, J6a,6b = 10.1 Hz, H-6a), 3.91
(dd, 1H, J5,6a = 3.8, J6a,6b = 10.1 Hz, H-6b), 3.60 (m, 1H, J = 6.1 Hz,
H-20), 2.02 (ddd, 1H, J3ax,4eq = 4.0, J2,3ax = J3ax,3eq = J3ax,4ax = 12.4 Hz,
H-3ax), 1.72–1.62 (m, 2H, H-3eq, H-4ax), 1.54 (m, 1H, H-4b), 1.55–
1.22 (m, 10H, CH2-30 to CH2-70), 1.03 (d, 3H, J = 6.1 Hz, CH3-10), 0.88
(t, 3H, J = 6.1 Hz, CH3-80); 13C NMR (CDCl3, 50.3 MHz) d 144.9,
129.9 (ꢃ2), 127.9, 127.8 (C-aromatic), 93.5 (C-1), 76.2 (C-2), 73.5
(C-20), 71.2 (C-5), 65.6 (C-6), 37.0, 31.8, 29.3, 26.5, 25.8, 23.4, 22.6
(C-3, C-4, C-30 to C-70), 21.6 (2 ꢃ CH3Ar), 19.0, 14.1 (CH3-10, CH3-80).
Anal. Calcd for C28H40O8S2: C, 59.13; H, 7.09; S, 11.28. Found: C,
59.09; H, 7.19; S, 11.13.
77 °C; [a]
D = +9.2 (c 1.0, CHCl3); 1H NMR (CDCl3, 500 MHz) d 7.86
(d, 2H, J = 8.2 Hz, H-aromatic), 7.36 (d, 2H, J = 8.2 Hz, H-aromatic),
4.91 (dd, 1H, J2,3eq = 6.1, J2,3ax = 11.0 Hz, H-2), 4.53 (dddd, 1H,
0
J5,6 = 4.1, J4eq,5 = 4.3, J5,6 = 4.8, J4ax,5 = 11.4 Hz, H-5), 3.52 (dd, 1H,
4.2.5. 2-(S)-Octyl 6-azido-2-O-tosyl-3,4,6-trideoxy-a-D-erythro-
hexopyranoside 7
0
0
0
J5,6 = 4.1, J6,6 = 14.2 Hz, H-6), 3.42 (dd, 1H, J5,6 = 4.8, J6,6
=
14.2 Hz, H-60), 2.48 (m, 1H, H-3eq), 2.44 (s, 3H, CH3Ar), 2.20 (dddd,
1H, J3ax,4eq = 4.3, J2,3ax = 11.0, J3ax,3eq = J3ax,4ax = 13.0 Hz, H-3ax), 2.03
(dddd, 1H, J3ax,4eq = J3eq,4eq = J4eq,5 = 4.3, J4ax,4eq = 14.6 Hz, H-4eq),
Compound 6 (1.78 g, 3.13 mmol) was dissolved in DMF (30 mL)
and NaN3 (427 mg, 6.57 mmol) was added. The reaction mixture
was stirred at 125 °C for 2 h, when TLC showed complete con-
sumption of the starting material and formation of a less polar
product (Rf = 0.75, hexane/EtOAc 2:1). The mixture was filtered
and the solvent evaporated in vacuo. The residue was purified by
column chromatography (hexane/EtOAc 96:4) to give 7 (1.27 g,
1.94 (dddd, 1H, J3eq,4ax = 4.3, J4ax,5 = 11.4, J3ax,4ax = 13.0, J4ax,4eq
=
14.6 Hz, H-4ax); 13C NMR (CDCl3, 125.7 MHz) d 165.0 (C-1), 145.4,
132.8, 129.8, 128.2 (C-aromatic), 79.2 (C-5), 73.4 (C-2), 53.9
(C-6), 27.2 (C-3), 24.4 (C-4), 21.7 (CH3Ar). Anal. Calcd for
C13H15O5SN3: C, 47.99; H, 4.65; S, 9.86; N, 12.92. Found: C,
92%); [a]
D = +77.9 (c 1.0, CHCl3). 1H NMR (CDCl3, 500 MHz) d 7.80
48.20; H, 4.60; S, 9.95; N, 12.83.
(d, 2H, J = 8.2 Hz, H-aromatic), 7.34 (d, 2H, J = 8.2 Hz, H-aromatic),
4.85 (d, 1H, J1,2 = 3.3 Hz, H-1), 4.41 (ddd, 1H, J1,2 = 3.3, J2,3eq = 4.8,
J2,3ax = 12.3 Hz, H-2), 3.98 (dddd, 1H, J4eq,5 ꢂ J5,6b = 3.6, J4ax,5 = 9.6,
4.2.8. Methyl (2S,5S)-5-(azidomethyl)-tetrahydrofuran-2-
carboxylate 10
J5,6a = 7.0 Hz, H-5), 3.71 (m, J = 6.1 Hz, H-20), 3.21 (dd, 1H, J5,6a
=
A solution of 9 (200 mg, 0.61 mmol) in MeOH (12 mL) was
stirred with potassium carbonate (84 mg, 0.61 mmol) at 20 °C.
After 1 h, TLC (hexane/EtOAc 1:1) showed total conversion of
the starting material into a less polar product (Rf = 0.73). The
reaction mixture was neutralized with Dowex 50W(H+), filtered
and was concentrated. The residue was subjected to flash chro-
7.0, J6a,6b = 13.0 Hz, H-6a), 3.12 (dd, 1H, J5,6b = 3.6, J6a,6b = 13.0 Hz,
H-6b), 2.44 (s, 3H, CH3Ar), 2.07 (dddd, 1H, J3ax,4eq = 4.3, J2,3ax
J3ax,4ax ꢂ J3ax,3eq = 12.3 Hz, H-3ax), 1.74 (dddd, 1H, J3eq,4ax = J3eq,4eq
ꢂ
=
3.8, J2,3eq = 4.8, J3ax,3eq = 12.3 Hz, H-3eq), 1.68–1.57 (m, 2H, H-4ax,
H-4eq), 1.51–1.23 (m, 10H, CH2-30 to CH2-70), 1.07 (d, 3H,
J = 6.1 Hz, CH3-10), 0.88 (t, 3H, J = 6.1 Hz, CH3-80); 13C NMR (CDCl3,
50.3 MHz) d 144.8, 134.0, 129.9, 127.7 (C-aromatic), 93.5 (C-1),
76.5 (C-2), 73.6 (CHO), 67.4 (C-5), 54.4 (C-6), 37.1, 31.8, 29.3,
27.8, 25.8, 23.6, 22.6 (C-3, C-4, C-30 to C-70), 21.6 (CH3Ar), 19.1,
14.1 (2 ꢃ CH3). Anal. Calcd for C21H33N3O5S: C, 57.38; H, 7.57; N,
9.56. Found: C, 57.49; H, 7.77; N, 9.61.
matography (hexane/EtOAc 9:1) to afford 10 as
a syrup
(106 mg, 86%);
[a]
D = ꢀ8.8 (c 0.2, CHCl3); 1H NMR (CDCl3,
500 MHz) d 4.63 (dd, 1H, J = 5.3, 8.0 Hz, H-2), 4.43 (dddd, 1H,
J = 4.1, 4.6, 7.0, 7.0 Hz, H-5), 3.78 (s, 3H, CH3O), 3.52 (dd, 1H,
J = 4.1, 12.9 Hz, H-6), 3.26 (dd, 1H, J = 4.7, 12.9 Hz, H-60), 2.37
(m, 1H, H-3), 2.09 (m, 2H, H-30, H-4), 1.84 (m, 1H, H-40); 13C
NMR (CDCl3, 125.7 MHz) d 173.4 (C-1), 79.0 (C-5), 77.3 (C-2),
54.1 (C-6), 52.1 (CH3O), 30.2 (C-3), 27.9 (C-4). HRMS-ESI: Calcd
for (C7H11N3O3 + H+) = 186.0873. Found = 186.0877. Calcd for
(C7H11N3O3 + Na+) = 208.0697. Found = 208.0697.
4.2.6. 6-Azido-2-O-tosyl-3,4,6-trideoxy-a,b-D-erythro-
hexopyranose 8
Compound 7 (673 mg, 1.53 mmol) was suspended in a mixture
of TFA (5 mL) and water (1.40 mL) and externally heated at 90 °C